Quarterly ResultApr 30, 2026, 04:22 PM
SYK Q1 Net Sales +2.6% to $6.0B; Reported EPS $1.93 (+14.2%)
AI Summary
Stryker Corporation reported Q1 2026 operating results with net sales increasing 2.6% to $6.0 billion and reported diluted EPS rising 14.2% to $1.93. Adjusted diluted EPS decreased 8.5% to $2.60, and adjusted operating income margin contracted by 180 bps to 21.1%. The company maintained its full-year 2026 guidance for organic net sales growth (8.0%-9.5%) and adjusted EPS ($14.90-$15.10), citing strong underlying business momentum and recovery from a cyber incident. Stryker also announced a new Ortho Tech business to streamline its orthopaedic portfolio.
Key Highlights
- Reported net sales increased 2.6% to $6.0 billion.
- Organic net sales grew 2.4% in Q1 2026.
- Reported diluted EPS rose 14.2% to $1.93.
- Adjusted diluted EPS decreased 8.5% to $2.60.
- MedSurg and Neurotechnology net sales increased 5.0% to $3.2 billion.
- Orthopaedics net sales increased 0.1% to $2.8 billion.
- Maintaining 2026 organic net sales growth guidance of 8.0% to 9.5%.
- Maintaining 2026 adjusted EPS guidance of $14.90 to $15.10.